Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3037-3044

  Sova, Henri ^a   Kangas, Juha ^a   Puistola, Ulla ^a   Santala, Markku ^a   Liakka, Annikki ^a   Karihtala, Peeter ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antioxidant enzymes; Ovarian cancer; Oxidative stress; Peroxiredoxin II, 8 hydroxydeoxyguanosine; Reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; PEROXIREDOXIN 2;

ADULT; ARTICLE; CANCER CELL; CYTOPLASM; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIOSIS ASSOCIATED OVARY CANCER; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DEOXYGUANOSINE; DOWN-REGULATION; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; PEROXIREDOXINS;

EID: 84865687645     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cramer DW and Missmer SA: The epidemiology of endometriosis. Ann NY Acad Sci 955: 11-22, 2002. (Pubitemid 34271058)
2. Pritts EA and Taylor RN: An evidence-based evaluation of endometriosis associated infertility. Endocrinol Metab Clin North Am 32: 653-667, 2003. (Pubitemid 37187068)
3. Jackson LW, Schisterman EF, Dey-Rao R, Browne R and Armstrong D: Oxidative stress and endometriosis. Hum Reprod 20: 2014-2020, 2005. (Pubitemid 40932392)
4. Gupta S, Agarwal A, Krajcir N and Alvarez JG: Role of oxidative stress in endometriosis. Reprod Biomed Online 13: 126-134, 2006. (Pubitemid 44054856)
5. Verit FF, Erel O and Celik N: Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod 23: 100-104, 2008. (Pubitemid 351767315)
6. Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, Papadias C and Greatsas G: Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril 91: 46-50, 2009.
7. Ngô C, Chéreau C, Nicco C, Weill B, Chapron C and Batteux F: Reactive oxygen species controls endometriosis progression. Am J Pathol 175: 225-234, 2009.
8. Kao SH, Huang HC, Hsieh RH, Chen SC, Tsai MC and Tzeng CR: Oxidative damage and mitochondrial DNA mutations with endometriosis. Ann NY Acad Sci 1042: 186-194, 2005.
9. Matsuzaki S and Schubert B: Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril 93: 2431-2432, 2010.
10. Ota H, Igarashi S, Hatazawa J and Tanaka T: Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil Steril 72: 129-134, 1999. (Pubitemid 29300274)
11. Matos L, Stevenson D, Gomes F, Silva-Carvalho JL and Almeida H: Superoxide dismutase expression in human cumulus oophorus cells. Mol Hum Reprod 15: 411-419, 2009.
12. Szczepañska M, Koźlik J, Skrzypczak J and Mikołajczyk M: Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79: 1288-1293, 2003.
13. Hirano T: Repair system of 7, 8-dihydro-8-oxoguanine as a defense line against carcinogenesis. J Radiat Res 49: 329-340, 2008.
14. Kasai H: Analysis of a form of oxidative DNA damage, 8-hydroxy-2′ deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis: Mutation Res 387: 147-163, 1997.
15. Wu LL, Chiou CC, Chang PY and Wu JT: Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics: Clin Chim Acta 339: 1-9, 2004. (Pubitemid 37542453)
16. Evans MD, Dizdaroglu M and Cooke MS: Oxidative DNA damage and disease: induction, repair and significance. Mutation Res 567: 1-61, 2004. (Pubitemid 39162992)
17. Karihtala P and Puistola U: Hypoxia and oxidative stress in the pathogenesis of gynecological cancers and in therapeutical options: Curr Canc Ther Rev 7: 37-55, 2011.
18. Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, Louisot P and Lunardi J: Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site: J Biol Chem 277: 19396-19401, 2002. (Pubitemid 34967447)
19. Pylväs M, Puistola U, Kauppila S, Soini Y and Karihtala P: Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis. Eur J Cancer 46: 1661-1667, 2010.
20. Lee TH, Kim SU, Yu SL, Kim SH, Park DS, Moon HB, Dho SH, Kwon KS, Kwon HJ, Han YH, Jeong S, Kang SW, Shin HS, Lee KK, Rhee SG and Yu DY: Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 10: 5033-5038, 2003. (Pubitemid 36857770)
21. Wang Y, Feinstein SI, Manevich Y, Ho YS and Fisher AB: Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress. Antioxid Redox Signal 8: 229-237, 2006. (Pubitemid 43324549)
22. Masaki Mandai, Ken Yamaguchi, Noriomi Matsumura, Tsukasa Baba and Ikuo Konishi: Ovarian cancer in endometriosis: Molecular biology, pathology, and clinical management. Int J Clin Oncol 14: 383-391, 2009.
23. Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C and Nezhat C: The relationship of endometriosis and ovarian malignancy: A review. Fertil Steril 90: 1559-1570, 2008.
24. Munksgaard PS and Blaakaer J: The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations. Gynecol Oncol 124: 164-169, 2012.
25. Toon Van Gorp, Frederic Amant, Patrick Neven and Ignace Vergote: Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 18: 349-371, 2004.
26. Ness RB and Modugno F: Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 42: 691-703, 2006.
27. Lin HW, Tu YY, Lin SY, Su WJ, Lin WL, Lin WZ, Wu SC and Lai YL: Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study. Lancet Oncol 12: 900-904, 2011.
28. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA and Huntsman DG: ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532-1543, 2010.
29. Tavassoéli FA and Devilee P: Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; WHO 2003.
30. Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review). Oncol Rep 22: 233-240, 2009.
31. Szczepanska M, Kozlik J, Skrzypczak J and Mikolajczyk M: Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79: 1288-1293, 2003.
32. Murphy A, Palinski W, Rankin S, Morales A and Parthasarathy S: Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril 69: 1092-1094, 1998. (Pubitemid 28274899)
33. Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol 25: 39-52, 2009.
34. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14: 32-40, 2008. (Pubitemid 351377975)
35. Karihtala P, Kauppila S, Puistola U and Jukkola-Vuorinen A: Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype. Br J Cancer 106: 344-347, 2012.
36. Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S and Karihtala P: 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 102: 1018-1023, 2010.
37. Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL and Soini Y: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424, 2003.
38. Sheridan J, Wang LM, Tosetto M, Sheahan K, Hyland J, Fennelly D, O'Donoghue D, Mulcahy H and O'Sullivan J: Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer 100: 381-388, 2009.
39. Murtas D, Piras F, Minerba L, Ugalde J, Floris C, Maxia C, Demurtas P, Perra MT and Sirigu P: Nuclear 8-hydroxy-2′- deoxyguanosine as survival biomarker in patients with cutaneous melanoma. Oncol Rep 23: 329-35, 2010.
40. Pasanen AK, Kuitunen H, Haapasaari KM, Karihtala P, Kyllönen H, Soini Y, Turpeenniemi-Hujanen T and Kuittinen O: Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas. Leuk Lymphoma 53: 624-631, 2012.
41. Woolston CM, Storr SJ, Ellis IO, Morgan DA and Martin SG: Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy-treated early-stage breast cancer. Radiother Oncol 100: 308-313, 2011.
42. Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Kärjä V and Karihtala P: 8-Hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol 4: 267-275, 2011.
43. Sanchez M, Torres JV, Tormos C, Iradi A, Muñiz P, Espinosa O, Salvador A, Rodriguez-Delgado J, Fandos M and Sáez GT: Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2′-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community. Cancer Lett 233: 28-35, 2006. (Pubitemid 43214561)
44. Karihtala P, Soini Y, Vaskivuo L, Bloigu R and Puistola U: DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer 19: 1047-1051, 2009.
45. Pylväs M, Puistola U, Laatio L, Kauppila S and Karihtala P: Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer. Anticancer Res 31: 1411-1415, 2011.
46. McMeekin DS, Burger RA, Manetta A, DiSaia P and Berman ML: Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol 59: 81-86, 1995.
47. Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y and Nozawa S: Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol 72: 342-346, 1999. (Pubitemid 29118191)
48. Banz C, Ungethuem U, Kuban RJ, Diedrich K, Lengyel E and Hornung D: The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer. Fertil Steril 94: 1212-1217, 2010.